Equillium
phase first in human study of single ascending dose multiple ascending dose proof of concept study in celiac disease patients | Equillium
Company
Deck Type
Sector
Industry
Deck date
August 2023
Slide
33 of 39
Similar slides by Equillium
See diffirences between slides (animation)
Investor Presentation
November 2023
phase first in human study of single ascending dose multiple ascending dose proof of concept study in celiac disease patients | Equillium
Related slides by other companies
NeuroSense Therapeutics
Investor Presentation
January 2024
randomized prospective double blind placebo controlled study phase design placebo controlled road | NeuroSense Therapeutics
MindMed
Results
May 2022
phase study results key phase study results support progression of into planned upcoming phase clinical program well tolerated up to per day in single ascending dose sad and per day in the multiple ascending dose mad linear maintained across the tested doses and frequencies clinical effects align with potent engagement regimen aligns with preclinical evidence offers potential to be a more effective regimen in withdrawal | MindMed
NeuroSense Therapeutics
Investor Presentation
December 2023
randomized prospective double blind placebo controlled study phase design placebo controlled road | NeuroSense Therapeutics
Aeglea BioTherapeutics
Investor Presentation
October 2023
combination programs summary wot | Aeglea BioTherapeutics
Other recent decks by Equillium
See all presentations (5 decks)
Investor Presentation
February 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Results
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io